Patents by Inventor Runxiang Qiu

Runxiang Qiu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CANCER TREATMENT BY TARGETING PROTEINS OR INTERACTIONS OF EPHRINB-RGS3-KIF20A-SEPT7 AXIS
    Publication number: 20240240189
    Abstract: A method of treating cancer in a subject by targeting at least one of KIF20A, SEPT7, RGS3 and EphrinB or disrupting protein-protein interaction in the EPHRINB-RGS3-KIF20A-SEPT7 axis. The method entails administering to the subject an RNA-based inhibitor such as an siRNA, shRNA, or miRNA or a peptide inhibitor which targets at least one of KIF20A, SEPT7, RGS3 and EphrinB or blocks the binding of KID20A to RGS3 and/or SEPT7 or the binding of EphrinB and RGS3.
    Type: Application
    Filed: April 6, 2022
    Publication date: July 18, 2024
    Applicant: CITY OF HOPE
    Inventors: Qiang LU, Runxiang QIU
  • LOSS OF 5-HYDROXYMETHYLCYTOSINE AS A BIOMARKER FOR CANCER
    Publication number: 20140030727
    Abstract: Methods for detecting or diagnosing cancer in a subject are provided herein. Such methods may include, but are not limited to, measuring a test level of 5hmC in a biological sample from the subject; and determining that the subject has a malignant cancer when the test level of 5hmC is lower than that of a control level of 5hmC. Such methods may further include a step of measuring a test level of Ki67 in the biological sample and determining that the subject has a malignant cancer when the test level of Ki67 is higher than that of a control level of Ki67.
    Type: Application
    Filed: January 22, 2013
    Publication date: January 30, 2014
    Inventors: Gerd Pfeifer, Seung-Gi Jin, Yong Jiang, Runxiang Qiu, Qiang Lu